The Schwab U.S. Dividend Equity ETF™ is confronting persistent investor outflows as market sentiment shifts away from high-dividend strategies. Despite its defensive sector positioning, the fund is posting clear losses, raising questions for income-focused investors.
Performance Metrics Signal Downturn
Recent trading data paints a concerning picture, with the ETF firmly entrenched in a downward trajectory. Last week saw SCHD decline by 0.96%, extending to a 1.28% monthly drop. While the fund maintains a 2.80% year-over-year gain, the current momentum is troubling market observers.
The fund does maintain strong liquidity, evidenced by robust trading volume exceeding 18 million shares. Additionally, the minimal -0.02% discount to net asset value indicates the market price closely mirrors intrinsic worth. However, these technical strengths provide little comfort amid the prevailing negative trend.
Concentration Risks in Top Holdings
SCHD’s core portfolio represents a veritable who’s who of American dividend aristocrats, though this focus introduces specific vulnerabilities:
Should investors sell immediately? Or is it worth buying Schwab U.S. Dividend Equity ETF™?
- Healthcare heavyweights AbbVie Inc. (4.35%) and Merck & Co. (4.19%)
- Technology representative Cisco Systems (4.35%)
- Amgen (4.17%) and Coca-Cola (4.12%) completing the top five positions
With 41% of assets concentrated in its ten largest holdings, the ETF maintains moderate allocation density—a potential liability during market turbulence. The sector allocation emphasizing energy (19.3%), consumer staples (18.7%), and healthcare (16.4%) traditionally offers stability but currently appears to be dragging on performance.
Competitive Landscape Intensifies
As SCHD struggles, competing products are vying for investor attention. The Vanguard Dividend Appreciation ETF (VIG) and iShares Core Dividend Growth ETF (DGRO) both target similar investor demographics with varying methodologies, yet share the common objective of delivering consistent distributions with manageable risk.
The fundamental challenge emerges from the current investment climate’s preference for growth equities over dividend payers. SCHD’s net outflows provide concrete evidence of this strategic shift occurring across markets.
Ad
Schwab U.S. Dividend Equity ETF™ Stock: Buy or Sell?! New Schwab U.S. Dividend Equity ETF™ Analysis from February 7 delivers the answer:
The latest Schwab U.S. Dividend Equity ETF™ figures speak for themselves: Urgent action needed for Schwab U.S. Dividend Equity ETF™ investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Schwab U.S. Dividend Equity ETF™: Buy or sell? Read more here...
